|
|
| | Palbociclib Impurity 3 Basic information |
| Product Name: | Palbociclib Impurity 3 | | Synonyms: | Palbociclib Impurity 3;8-cyclopentyl-5-methyl-2,6-bis((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one;Pabuxirib Impurity G;3-(Tetramethyl-1,3,2-dioxaborolan-2-yl)propan-1-amine;3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)propan-1-amine trifluoroacetic acid;Trifluoroacetic acid salt | | CAS: | 2377610-25-6 | | MF: | C11H21BF3NO4 | | MW: | 299.1 | | EINECS: | | | Product Categories: | | | Mol File: | 2377610-25-6.mol |  |
| | Palbociclib Impurity 3 Chemical Properties |
| | Palbociclib Impurity 3 Usage And Synthesis |
| Uses | 8-Cyclopentyl-5-methyl-2,6-bis((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one is an impurity of Palbociclib (P139900),(also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
| | Palbociclib Impurity 3 Preparation Products And Raw materials |
|